Telmisartan |
Micardis |
Clinical Trial: Outcome Study ONTARGET
This study has been completed.
|
Purpose
A large, simple, randomized, double-blind, multicentre, international trial comparing the effects of Telmisartan, Ramipril, and their combination on outcomes in patients at high risk for cardiovascular events.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Coronary Disease Angina Pectoris Cerebrovascular Accident Myocardial Infarction | Drug: Telmisartan Drug: Ramipril | Phase IV |
MedlinePlus related topics: Angina; Coronary Disease; Heart Attack; Stroke
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Ongoing Telmisartan alone and in combination with Ramipril Global Endpoint Trial
Eligibility
Ages Eligible for Study: 55 Years and above, Genders Eligible for Study: Both
Criteria
INCLUSION CRITERIA:
Male or female subjects, 55 years of age or older, and at high risk of developing a major CVD event are eligible if they have any of the following:
Coronary artery disease:
- Previous myocardial infarction (> 2 days post uncomplicated MI, prior to informed consent).
- Stable angina or unstable angina [(> 30 days prior to informed consent) each with documented multi-vessel coronary disease, > 50% stenosis in at least two major coronary arteries on coronary angiography, or positive stress test (ST depression > 2 mm or a positive nuclear perfusion scintigram)].
- Multi-vessel PTCA > 30 days prior to informed consent.
- Multi-vessel CABG surgery > 4 years prior to informed consent, or with recurrent angina following surgery.
Peripheral arterial disease:
- Previous limb bypass surgery or percutaneous transluminal angioplasty.
- Previous limb or foot amputation.
- History of intermittent claudication, with an ankle: arm blood pressure ratio < 0.80 on at least one side.
- Significant peripheral artery stenosis (> 50%) documented by angiography or non-invasive testing.
- Previous Stroke
- TIA > 7 days and < 1 year prior to informed consent.
- High-risk diabetics (insulin-dependent or non-insulin-dependent) with evidence of end-organ damage: retinopathy, LVH, macro or microalbuminuria, or any evidence of previous cardiac or vascular disease.
EXCLUSION CRITERIA:
Patients will be excluded if any one of the following criteria is met.
Medication use:
- Inability to discontinue ACE-inhibitors or AIIA.
- Patients with known hypersensitivity or intolerance to AIIA’s or ACE-inhibitors.
Cardiovascular disease:
- Symptomatic congestive heart failure.
- Hemodynamically significant primary valvular or outflow tract obstruction (e.g. aortic or mitral valve stenosis, asymmetric septal hypertrophy, malfunctioning prosthetic valve).
- Constrictive pericarditis.
- Complex congenital heart disease.
- Syncopal episodes of unknown etiology < 3 months before informed consent.
- Planned cardiac surgery or angioplasty within three months.
- Uncontrolled hypertension on treatment (i.e. BP > 160/100).
- Heart transplant recipient.
- Strokes due to subarachnoid hemorrhage.
Other conditions:
- Significant renal disease defined as:
- Renal artery stenosis;
- Creatinine clearance < 0.6 ml/min or serum creatinine > 265 mmol/L (> 3.0 mg/dL);
- Hyperkalemia: potassium > 5.5 mmol/L.
- Hepatic dysfunction as defined by the following laboratory parameters: SGPT (ALT) or SGOT (AST) > than 4 times upper limit of normal or additional criteria for hepatic impairment the upper limit of normal range, total Bilirubin > 20 mmol/L, biliary obstructive disorders.
- Uncorrected volume depletion or sodium depletion.
- Primary aldosteronism.
- Hereditary fructose intolerance.
- Any other major non-cardiac illness expected to reduce life expectancy or interfere with study participation.
- Patient is simultaneously taking another experimental drug.
- Patient with significant disability that precludes regular attendance at clinic for follow-up.
- Patient has sufficient disability or other incapacity that precludes regular attendance at clinic for follow-up.
- Unable or unwilling to provide written informed consent.
Location Information
Alabama
University of Alabama at Birmingham, Birmingham, Alabama, 35294-2041, United States
Athens Internal Medicine, Athens, Alabama, 35611, United States
Arizona
VAMC Phoenix, Phoenix, Arizona, 85012, United States
Saguaro Clinical Research, Tucson, Arizona, 85712, United States
Tucson VA Medical Center, Tucson, Arizona, 85723, United States
Maricopa Medical Center, Phoenix, Arizona, 85008, United States
Arkansas
Garrett-Gross Clinic Ltd, Bentonville, Arkansas, 72712, United States
California
University of California Davis Medical Center, Sacramento, California, 95817, United States
John Muir, Mt. Diablo Health Network: East Bay Clinical Trials, Concord, California, 94520, United States
Naval Medical Center San Diego, San Diego, California, 92134, United States
Kaiser Permanente, Los Angeles, California, 90027, United States
Schultz Clinic, San Leandro, California, 94578, United States
Affiliates in Medical Specialties, Medical Groups, West Hills, California, 91307, United States
Kaiser Permanente, Harbor City, California, 90710, United States
Olive View Education and Research Center, Sylmar, California, 91342, United States
Loma Linda VA Medical Center, Loma Linda, California, 92354, United States
Connecticut
Cardiac Assoc. of Southern CT, Bridgeport, Connecticut, 06606, United States
University of CT Healthcare Center, Farmington, Connecticut, 06030-3940, United States
District of Columbia
Howard University Hospital, Washington, District of Columbia, 20060, United States
Florida
Cleveland Clinic Florida, Weston, Florida, 33331, United States
Springfield Medical Center, Panama City, Florida, 32401, United States
Shands Teaching Hospital @ Univ. of Florida, Gainesville, Florida, 32610, United States
Palm Harbor Medical Associates, Palm Harbor, Florida, 34684, United States
Treasure Coast Infectious Disease Consultants (TCIDC), Vero Beach, Florida, 32960, United States
Medical Research Institute, Tampa, Florida, 33607, United States
Georgia
Kaiser Permanente of Georgia, Tucker, Georgia, 30084, United States
Southern Clinical Research and Management, Inc. (Medical Village), Augusta, Georgia, 30904, United States
Ellison Clinic, Conyers, Georgia, 30094, United States
VAMC Augusta (509/242), Augusta, Georgia, 30904, United States
St. Joseph's Candler Health System, Savannah, Georgia, 31405, United States
Val-Oak Professional Corporation, Valdosta, Georgia, 31602, United States
Medical College of Georgia, Augusta, Georgia, 30912, United States
Primary Care Center, Sandersville, Georgia, 31082, United States
Idaho
Idaho State University, Pocatello, Idaho, 83209-8357, United States
Illinois
Suburban Heights Medical Center, Chicago Heights, Illinois, 60411-1790, United States
Cook County Hospital General Medicine Clinic; Fantis Health Center, Chicago, Illinois, 60612, United States
Cardiology-Internal Medicine Associates, S.C., Oak Lawn, Illinois, 60453, United States
Iowa
Iowa Heart Center, Des Moines, Iowa, 50314, United States
Louisiana
Cardiac Centers of Louisiana, LLC, Shreveport, Louisiana, 71103-3971, United States
Medicine II Clinic - E.A. Conway Hospital, Monroe, Louisiana, 71201, United States
Maryland
Model Clinical Research LLC, Baltimore, Maryland, 21204, United States
Massachusetts
Baystate Medical Center, Springfield, Massachusetts, 01199, United States
Massachusetts General Hospital, Boston, Massachusetts, 02114, United States
Michigan
Henry Ford Hospital, Detroit, Michigan, 48202, United States
Minnesota
Minneapolis VAMC (111C1), Minneapolis, Minnesota, 55417, United States
Berman Center for Outcomes and Clinical Research, Minneapolis, Minnesota, 55404, United States
Regions Hospital Cardiology Research, St. Paul, Minnesota, 55101, United States
Mississippi
Mid Delta Family Practice Clinic, Cleveland, Mississippi, 38732, United States
VA Gulf Coast Veterans Health Care System, Biloxi, Mississippi, 39531-2410, United States
Phillips Medical Services, Jackson, Mississippi, 39209, United States
Missouri
VAMC St. Louis, St. Louis, Missouri, 63106, United States
People's Health Centers, St. Louis, Missouri, 63112, United States
VAMC Kansas City, Kansas City, Missouri, 64128-2295, United States
Nebraska
Creighton University Cardiac Center, Omaha, Nebraska, 68131-2044, United States
Nevada
VAMC Las Vegas, Las Vegas, Nevada, 89106, United States
New Jersey
Cooper Hospital/UMC Department of Medicine, Camden, New Jersey, 08103, United States
Westwood Cardiology Associates, Westwood, New Jersey, 07675, United States
UMDNJ - New Jersey Medical School, Newark, New Jersey, 07103, United States
VAMC East Orange, East Orange, New Jersey, 07018-1095, United States
New York
Great Lakes Medical Research/Westfield Family Physicians, Westfield, New York, 14787, United States
SUNY Downstate, Brooklyn, New York, 11203, United States
Kaleida Health, Buffalo, New York, 14203, United States
Bronx Nephrology Hypertension PC, Bronx, New York, 10467, United States
VAMC Northport Medical Services (111), Northport, New York, 11768, United States
VA New York Harbor Healthcare System, New York, New York, 10010, United States
Cardiology & Internal Medicine, Williamsville, New York, 14221, United States
University of Rochester Medical Center, Rochester, New York, 14642, United States
Westchester Cardiology Associates, Scarsdale, New York, 10583, United States
Rochester Cardiopulmonary Group, Rochester, New York, 14621, United States
Mid Valley Cardiology, Kingston, New York, 12401, United States
Dr. Maurer, New York, New York, 10034, United States
North Carolina
Duke University Medical Center, Durham, North Carolina, 27713, United States
Wake Forest University Baptist Medical Center/School of Medicine, Winston Salem, North Carolina, 27157-1032, United States
North Dakota
VAMC Fargo, Fargo, North Dakota, 68102, United States
Ohio
Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States
The Lindner Research Center, Cincinnati, Ohio, 45219, United States
Wright State University VA Campus, Dayton, Ohio, 45428, United States
North Central Ohio Clinic, Inc., Mansfield, Ohio, 44903, United States
Oklahoma
Plaza Medical Group, Oklahoma City, Oklahoma, 73112, United States
University of Oklahoma College of Medicine - Tulsa, Tulsa, Oklahoma, 74129, United States
Oklahoma Foundation for Cardiovascular Research, Oklahoma City, Oklahoma, 73104, United States
Ringrose Clinic, Inc., Guthrie, Oklahoma, 73044, United States
Oregon
Portland Cardiovascular Institute, Portland, Oregon, 97216, United States
Pennsylvania
Buxmont Cardiology Associates, Sellersville, Pennsylvania, 18960, United States
Cardiology Consultants of Philadelphia, Philadelphia, Pennsylvania, 19148, United States
Osteopathic Internal Medicine Associates, Erie, Pennsylvania, 16508, United States
South Carolina
VAMC Charleston, Charleston, South Carolina, 29401, United States
University of South Carolina School of Medicine, Columbia, South Carolina, 29203, United States
Texas
VA Hospital, Houston, Texas, 77030, United States
Research Institute of Dallas, Dallas, Texas, 75231, United States
Drummond Clinic, Dallas, Texas, 75235, United States
Clinical Cardiology Research Center, Dallas, Texas, 75246, United States
Frood Eelani, DO - Internal Medicine, Fort Worth, Texas, 76104, United States
VAMC Houston, Houston, Texas, 77030, United States
UT-Southwestern Medical Center, Dallas, Texas, 75390-9047, United States
Baylor College of Medicine: Neurology Dept., Houston, Texas, 77030, United States
Virginia
Clincial Research Institute of Northern VA, Springfield, Virginia, 22151, United States
Washington
University of Washington, Seattle, Washington, 98195, United States
Wisconsin
VAMC Milwaukee, Milwaukee, Wisconsin, 53295, United States
Puerto Rico
Orocovis Medical Center, Orocovis, 00720, Puerto Rico
Colon-Ortiz Clinic, Caguas, 00726, Puerto Rico
Policlinica Familiar Monaco, Manati, 00674, Puerto Rico
Miguel Sosa-Padilla, MD-Private Practice, Rio Piedras, 00926, Puerto Rico
Centro Clinico San Patricio, Las Lomas, 00921, Puerto Rico
More Information
Record last reviewed: May 2004
Last Updated: October 13, 2004
Record first received: May 2, 2002
ClinicalTrials.gov Identifier: NCT00034931
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Micardis (Drug Digest)
- Micardis Consumer Information (U.S. Food and Drug Administration)

Not Signed In -


